PL1868642T3 - Białka fuzyjne alergenów kocich i ich zastosowania - Google Patents
Białka fuzyjne alergenów kocich i ich zastosowaniaInfo
- Publication number
- PL1868642T3 PL1868642T3 PL06725140T PL06725140T PL1868642T3 PL 1868642 T3 PL1868642 T3 PL 1868642T3 PL 06725140 T PL06725140 T PL 06725140T PL 06725140 T PL06725140 T PL 06725140T PL 1868642 T3 PL1868642 T3 PL 1868642T3
- Authority
- PL
- Poland
- Prior art keywords
- fusion proteins
- cat allergen
- allergen fusion
- cat
- proteins
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66291805P | 2005-03-18 | 2005-03-18 | |
EP06725140.5A EP1868642B1 (en) | 2005-03-18 | 2006-03-17 | Cat allergen fusion proteins and uses thereof |
PCT/EP2006/060845 WO2006097530A2 (en) | 2005-03-18 | 2006-03-17 | Cat allergen fusion proteins and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1868642T3 true PL1868642T3 (pl) | 2013-10-31 |
Family
ID=36843236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06725140T PL1868642T3 (pl) | 2005-03-18 | 2006-03-17 | Białka fuzyjne alergenów kocich i ich zastosowania |
Country Status (19)
Country | Link |
---|---|
US (3) | US7767212B2 (pl) |
EP (1) | EP1868642B1 (pl) |
JP (2) | JP5302671B2 (pl) |
KR (1) | KR20070112225A (pl) |
CN (2) | CN101141979B (pl) |
AU (1) | AU2006224529B2 (pl) |
BR (1) | BRPI0608455A2 (pl) |
CA (1) | CA2599218C (pl) |
CY (1) | CY1114171T1 (pl) |
DK (1) | DK1868642T3 (pl) |
ES (1) | ES2424229T3 (pl) |
IL (1) | IL185103A0 (pl) |
MX (1) | MX2007011160A (pl) |
NZ (1) | NZ561040A (pl) |
PL (1) | PL1868642T3 (pl) |
PT (1) | PT1868642E (pl) |
RU (1) | RU2414239C2 (pl) |
WO (1) | WO2006097530A2 (pl) |
ZA (1) | ZA200707413B (pl) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7264810B2 (en) * | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
DK1450856T3 (da) | 2001-09-14 | 2010-05-31 | Cytos Biotechnology Ag | Pakning af immunstimulatorisk CpG i virus-lignende partilker, fremgangsmåde og anvendelse |
EP2351770A1 (en) * | 2002-07-17 | 2011-08-03 | Cytos Biotechnology AG | Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
CA2492930C (en) * | 2002-07-19 | 2013-01-08 | Cytos Biotechnology Ag | Vaccine compositions containing amyloid beta1-6 antigen arrays |
KR20070112225A (ko) * | 2005-03-18 | 2007-11-22 | 사이토스 바이오테크놀로지 아게 | 고양이 알레르겐 컨쥬게이트 및 그의 용도 |
AU2006325225B2 (en) * | 2005-12-14 | 2013-07-04 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
WO2007113633A2 (en) * | 2006-04-03 | 2007-10-11 | Pfizer Products Inc. | Immunogenic compositions comprising cat allergen fel dl |
AT503690A1 (de) * | 2006-06-09 | 2007-12-15 | Biomay Ag | Hypoallergene moleküle |
US8541559B2 (en) | 2006-06-12 | 2013-09-24 | Cytos Biotechnology Ag | Process for producing aggregated oligonucleotides |
SI2601970T1 (sl) | 2006-09-29 | 2017-04-26 | Takeda Vaccines, Inc. | Formulacije cepiva proti norovirusu |
US9388236B2 (en) | 2007-07-09 | 2016-07-12 | Nestec Sa | Methods for reducing allergies caused by environmental allergens |
CN101686974A (zh) | 2007-07-09 | 2010-03-31 | 雀巢产品技术援助有限公司 | 减轻因环境过敏原导致的过敏症的方法 |
US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
SG10201601660YA (en) | 2007-09-18 | 2016-04-28 | Takeda Vaccines Inc | Method of conferring a protective immune response to norovirus |
EP2042193A1 (en) * | 2007-09-28 | 2009-04-01 | Biomay AG | RNA Vaccines |
JP5852883B2 (ja) | 2008-08-08 | 2016-02-03 | タケダ ワクチン,インコーポレイテッド | 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子 |
CA2816401C (en) * | 2009-11-05 | 2017-07-18 | Novici Biotech Llc | Generation of antigenic virus-like particles through protein-protein linkages |
US8321012B2 (en) * | 2009-12-22 | 2012-11-27 | The Invention Science Fund I, Llc | Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject |
AU2012282658B2 (en) | 2011-07-11 | 2014-11-27 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
KR20140107295A (ko) | 2011-12-22 | 2014-09-04 | 에프. 호프만-라 로슈 아게 | 진핵 세포용 전장 항체 표시 시스템 및 그것의 용도 |
JO3820B1 (ar) | 2012-05-03 | 2021-01-31 | Regeneron Pharma | أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها |
US9657076B2 (en) * | 2012-10-23 | 2017-05-23 | Emory University | GM-CSF and IL-4 conjugates, compositions, and methods related thereto |
EP3564671B1 (en) | 2013-08-23 | 2021-09-29 | Regeneron Pharmaceuticals, Inc. | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit) |
EP3082849B1 (en) | 2013-12-19 | 2019-11-06 | Société des Produits Nestlé S.A. | Uses of compositions and methods for reducing cat allergens in the environment |
MA40824A (fr) | 2014-10-22 | 2017-08-29 | Saiba Gmbh | Particules de cmv de type virus modifié |
DE16703049T1 (de) | 2015-01-15 | 2018-07-12 | University Of Copenhagen | Virusähnliche partikel mit effizienter epitopanzeige |
WO2016192788A1 (en) * | 2015-06-03 | 2016-12-08 | Universität Zürich Prorektorat Mnw | Methods and compositions for preventing and treating cat or dog dander allergy |
KR20180049061A (ko) * | 2015-09-08 | 2018-05-10 | 유니베르시태트 취리히 | 고양이 알레르기 억제 조성물 |
WO2017071713A1 (en) | 2015-10-30 | 2017-05-04 | University Of Copenhagen | Virus like particle with efficient epitope display |
CN105219742A (zh) * | 2015-11-10 | 2016-01-06 | 海南大学 | 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用 |
WO2017179025A1 (en) | 2016-04-15 | 2017-10-19 | Alk-Abelló A/S | Epitope polypeptides of ragweed pollen allergens |
FR3054547B1 (fr) * | 2016-07-29 | 2020-06-05 | Angany Inc. | Particules pseudo-virales et leurs utilisations |
WO2018118713A1 (en) | 2016-12-22 | 2018-06-28 | Regeneron Pharmaceuticals, Inc. | Method of treating an allergy with allergen-specific monoclonal antibodies |
US20220073946A1 (en) | 2018-12-20 | 2022-03-10 | Saiba AG | Virus-like particles of cmv modified by fusion |
WO2023176206A1 (ja) * | 2022-03-18 | 2023-09-21 | デンカ株式会社 | リンカーにより連結されたカプシドタンパク質を含むウイルス様粒子 |
CN114933639B (zh) * | 2022-05-05 | 2023-12-29 | 中国农业科学院兰州兽医研究所 | 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途 |
CN117004650A (zh) * | 2023-06-25 | 2023-11-07 | 山东立菲生物产业有限公司 | 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4163778A (en) * | 1978-05-04 | 1979-08-07 | The Foundation for the Study of Asthma and Related Diseases | Asthma immunotherapy |
US5374426A (en) | 1986-09-03 | 1994-12-20 | University Of Saskatchewan | Rotavirus nucleocapsid protein VP6 in vaccine compositions |
DE68924850T2 (de) | 1988-06-14 | 1996-10-10 | Cell Med Inc | Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren. |
US6120769A (en) | 1989-11-03 | 2000-09-19 | Immulogic Pharmaceutical Corporation | Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
WO1992011291A1 (en) | 1990-12-20 | 1992-07-09 | Smithkline Beecham Biologicals (S.A.) | Vaccines based on hepatitis b surface antigen |
GB9114003D0 (en) | 1991-06-28 | 1991-08-14 | Mastico Robert A | Chimaeric protein |
GB9213601D0 (en) | 1992-06-26 | 1992-08-12 | Mastico Robert A | Protein based delivery system |
NZ273815A (en) | 1994-09-02 | 1999-05-28 | Immulogic Pharma Corp | Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides |
US6759234B1 (en) | 1994-09-02 | 2004-07-06 | Immulogic Pharmaceutical Corporation | Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response |
CN1185811A (zh) | 1995-03-31 | 1998-06-24 | H·沃尔夫 | 依赖于逆转录病毒样颗粒的抗原呈递系统 |
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
US6054312A (en) | 1997-08-29 | 2000-04-25 | Selective Genetics, Inc. | Receptor-mediated gene delivery using bacteriophage vectors |
AU3179999A (en) | 1997-12-16 | 1999-07-05 | Regents Of The University Of Minnesota | Methods to treat undesirable immune responses |
AR020102A1 (es) | 1998-07-30 | 2002-04-10 | Ucb Sa | Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento |
WO2000020032A1 (en) | 1998-10-06 | 2000-04-13 | Trustees Of Dartmouth College | RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY |
EP1123114B1 (en) | 1998-10-21 | 2005-12-28 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Virus-like particles for the induction of autoantibodies |
NZ512456A (en) * | 1998-11-30 | 2003-10-31 | Cytos Biotechnology Ag | Ordered molecular presentation of antigens |
AP1775A (en) | 1999-09-25 | 2007-08-28 | Univ Iowa Res Found | Immunostimulatory nucleic acids. |
CA2407897A1 (en) * | 2000-05-05 | 2001-11-15 | Cytos Biotechnology Ag | Molecular antigen arrays and vaccines |
NZ525820A (en) | 2000-11-16 | 2005-01-28 | Alk Abello As | Mutant allergens |
DK1219300T3 (da) | 2000-12-28 | 2007-03-05 | Biomay Prod & Handel | Behandling af allergi |
EP1221317A1 (en) | 2000-12-28 | 2002-07-10 | SHAN-Beteiligungsgesellschaft m.b.H. | Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
US7264810B2 (en) | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
ATE448793T1 (de) | 2001-03-02 | 2009-12-15 | Univ Rockefeller | Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens |
WO2003024480A2 (en) | 2001-09-14 | 2003-03-27 | Cytos Biotechnology Ag | In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
DK1450856T3 (da) | 2001-09-14 | 2010-05-31 | Cytos Biotechnology Ag | Pakning af immunstimulatorisk CpG i virus-lignende partilker, fremgangsmåde og anvendelse |
CN1321695C (zh) * | 2001-11-07 | 2007-06-20 | 赛托斯生物技术公司 | 用于治疗变应性嗜酸细胞性疾病的展示il-5、il-3或嗜酸细胞活化趋化因子的抗原阵列 |
NZ532515A (en) * | 2001-11-07 | 2005-10-28 | Cytos Biotechnology Ag | Compositions comprising a RANKL peptide attached to a core or virus-like particle for treatment of bone disease and immunization |
EP2351770A1 (en) * | 2002-07-17 | 2011-08-03 | Cytos Biotechnology AG | Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
US20040076645A1 (en) | 2002-07-19 | 2004-04-22 | Bachmann Martin F. | Ghrelin-carrier conjugates |
EP1530585A2 (en) | 2002-08-22 | 2005-05-18 | Cytos Biotechnology AG | Inducible alphaviral/orip based gene expression system |
JP2006520184A (ja) | 2002-11-01 | 2006-09-07 | アルカベロ アクチェセルスカプ | 組換えタンパク質変種 |
MXPA05005528A (es) | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
ZA200507562B (en) * | 2003-03-26 | 2006-11-29 | Cytos Biotechnology Ag | HIV-peptide-carrier-conjugates |
ATE384741T1 (de) * | 2003-04-24 | 2008-02-15 | Imvision Gmbh | Rekombinantes fel d 1 allergen |
AU2004255470B2 (en) * | 2003-07-10 | 2010-08-19 | Cytos Biotechnology Ag | Packaged virus-like particles |
KR20070112225A (ko) * | 2005-03-18 | 2007-11-22 | 사이토스 바이오테크놀로지 아게 | 고양이 알레르겐 컨쥬게이트 및 그의 용도 |
-
2006
- 2006-03-17 KR KR1020077022225A patent/KR20070112225A/ko not_active Application Discontinuation
- 2006-03-17 ZA ZA200707413A patent/ZA200707413B/xx unknown
- 2006-03-17 RU RU2007138265/15A patent/RU2414239C2/ru not_active IP Right Cessation
- 2006-03-17 AU AU2006224529A patent/AU2006224529B2/en not_active Ceased
- 2006-03-17 EP EP06725140.5A patent/EP1868642B1/en not_active Not-in-force
- 2006-03-17 CN CN2006800088726A patent/CN101141979B/zh not_active Expired - Fee Related
- 2006-03-17 CN CN2013101152149A patent/CN103203016A/zh active Pending
- 2006-03-17 BR BRPI0608455-9A patent/BRPI0608455A2/pt active Search and Examination
- 2006-03-17 PL PL06725140T patent/PL1868642T3/pl unknown
- 2006-03-17 PT PT67251405T patent/PT1868642E/pt unknown
- 2006-03-17 CA CA2599218A patent/CA2599218C/en not_active Expired - Fee Related
- 2006-03-17 WO PCT/EP2006/060845 patent/WO2006097530A2/en active Application Filing
- 2006-03-17 MX MX2007011160A patent/MX2007011160A/es active IP Right Grant
- 2006-03-17 NZ NZ561040A patent/NZ561040A/en not_active IP Right Cessation
- 2006-03-17 DK DK06725140.5T patent/DK1868642T3/da active
- 2006-03-17 ES ES06725140T patent/ES2424229T3/es active Active
- 2006-03-17 JP JP2008501331A patent/JP5302671B2/ja not_active Expired - Fee Related
- 2006-03-17 US US11/886,577 patent/US7767212B2/en not_active Expired - Fee Related
-
2007
- 2007-08-07 IL IL185103A patent/IL185103A0/en not_active IP Right Cessation
-
2010
- 2010-05-21 US US12/785,174 patent/US20110045013A1/en not_active Abandoned
-
2012
- 2012-12-21 US US13/724,331 patent/US20130344098A1/en not_active Abandoned
-
2013
- 2013-03-12 JP JP2013048847A patent/JP2013155176A/ja active Pending
- 2013-07-26 CY CY20131100638T patent/CY1114171T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN101141979A (zh) | 2008-03-12 |
KR20070112225A (ko) | 2007-11-22 |
CY1114171T1 (el) | 2016-08-31 |
EP1868642B1 (en) | 2013-05-08 |
RU2414239C2 (ru) | 2011-03-20 |
NZ561040A (en) | 2009-04-30 |
MX2007011160A (es) | 2007-11-13 |
CN101141979B (zh) | 2013-05-08 |
CN103203016A (zh) | 2013-07-17 |
US20110045013A1 (en) | 2011-02-24 |
JP5302671B2 (ja) | 2013-10-02 |
US20130344098A1 (en) | 2013-12-26 |
JP2008535800A (ja) | 2008-09-04 |
EP1868642A2 (en) | 2007-12-26 |
DK1868642T3 (da) | 2013-06-24 |
WO2006097530A3 (en) | 2007-06-21 |
US7767212B2 (en) | 2010-08-03 |
JP2013155176A (ja) | 2013-08-15 |
CA2599218A1 (en) | 2006-09-21 |
RU2007138265A (ru) | 2009-04-27 |
ES2424229T3 (es) | 2013-09-30 |
PT1868642E (pt) | 2013-07-10 |
WO2006097530A2 (en) | 2006-09-21 |
US20090175896A1 (en) | 2009-07-09 |
AU2006224529B2 (en) | 2012-05-24 |
BRPI0608455A2 (pt) | 2010-01-05 |
ZA200707413B (en) | 2009-01-28 |
IL185103A0 (en) | 2007-12-03 |
CA2599218C (en) | 2015-08-11 |
AU2006224529A1 (en) | 2006-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200707413B (en) | Cat allergen fusion proteins and uses thereof | |
IL235620A0 (en) | sp35 antibodies and their uses | |
IL222922A (en) | Antibodies against neurophilin-1 and their use | |
PL1830872T3 (pl) | Białka fuzyjne | |
GB0426397D0 (en) | Fusion proteins | |
IL189246A0 (en) | Albumin fusion proteins | |
PL2650020T3 (pl) | Trimeryczne białko fuzyjne OX-4-immunoglobulina i sposoby stosowania | |
AP2008004471A0 (en) | Anti-Alpha2 Intergin antibodies and their uses | |
EP2007884A4 (en) | ENZYMATIC FUSION PROTEINS AND THEIR USE | |
EP1934372A4 (en) | SSB-POLYMERASE HYBRID PROTEINS | |
IL184024A0 (en) | Irta-5 antibodies and their uses | |
EP1960523A4 (en) | MODIFIED POREN FORMING PROTEIN TOXINS AND USE THEREOF | |
ZA200801224B (en) | Albumin fusion proteins | |
EP1904845A4 (en) | IMPROVED RESULTS AND APPLICATION OF COMPARISON EXAMPLES OF PROTEIN EXPRESSIONS | |
EP1878801A4 (en) | Protein splitting method and use thereof | |
GB0513878D0 (en) | Cat allergen | |
EP1877425A4 (en) | FLUORESCENT PROTEINS AND ITS USE | |
SI1868642T1 (sl) | Mačji alergen-fuzijski proteini in njihove uporabe | |
ZA200808656B (en) | Enzyme fusion proteins and their use | |
GB0417390D0 (en) | Chimeric proteins and uses thereof | |
IL179998A0 (en) | Chimeric proteins and uses thereof | |
HK1082770A1 (en) | Supter-antigen fusion proteins and the use thereof | |
GB0426399D0 (en) | Fusion proteins | |
AU2004901156A0 (en) | Cat allergen | |
AU2004902079A0 (en) | Cat allergen |